Alsactide

This classification denotes an amino acid, peptide, or protein with the molecular formula C99H155N29O21S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J0K70H3420, chemically known as 1-beta-alanine-17-(l-2,6-diamino-n-(4-aminobutyl)hexanamide)-alpha(sup 1-17)-corticotropin but generally known as alsactide, which bears US NIH Compound Identifier 16129705. European Medicines Agency schedules Alsactide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05374MIG. The term ALSACTIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules alsactide in its Anatomical Therapeutic Chemical (ATC) Classification. ALSACTIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alsactide under HS 29371900 and SITC 54154. As of Q4 2014, ALSACTIDE remains the US FDA Preferred Term for this commodity. SMILES: S(CCC(NC(=O)C(NC(=O)C(NC(=O)CCN)CC1CCC(O)CC1)CO)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N1C(CCC1)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NCCCCN)CCCCN)CC1C2C([NH]C1)CCCC2)CCCNC(=N)N)CC1CCCCC1)CC1[NH]CNC1)CCC(.